TABLE 1.
SND1 global regulation of metastatic and oncogenic signaling programs
GSEA of control versus SND1-KD microarray analysis indicated 55 gene sets significantly down-regulated in the SND1-KD condition (p < 0.01 and false discovery rate (FDR) <0.25). Significantly down-regulated gene sets pertinent to metastasis and/or oncogenic signaling (n = 17) are shown. Gene sets tested for enrichment were obtained from the C2 collection provided in the Molecular Signatures Database v3.0 of the Broad Institute GSEA server. Nom, nominal; NES, normalized enrichment score; DMOG, dimethyloxalyl glycine.
Gene set | Size | NES | Nom p value | FDR q value |
---|---|---|---|---|
Minn lung metastasis up-regulated genes | 43 | 2.25 | <0.001 | 0.006 |
Amit EGF response 40 HeLa | 38 | 2.14 | <0.001 | 0.015 |
Amit serum response 40 MCF10A | 28 | 2.13 | <0.001 | 0.013 |
Bild HRas oncogenic signature | 220 | 1.97 | <0.001 | 0.076 |
Amit EGF response 120 MCF10A | 39 | 1.83 | <0.001 | 0.117 |
Nagashima EGF signature up | 52 | 1.82 | <0.001 | 0.116 |
Elvidge hypoxia by DMOG up | 114 | 1.77 | <0.001 | 0.156 |
Tomlins prostate cancer up | 34 | 1.77 | <0.001 | 0.151 |
Mense hypoxia up | 80 | 1.77 | <0.001 | 0.149 |
Elvidge hypoxia up | 147 | 1.72 | <0.001 | 0.162 |
Farmer breast cancer cluster 7 | 19 | 1.72 | 0.005 | 0.160 |
Wang Barrett esophagus cancer up | 25 | 1.70 | 0.005 | 0.179 |
Winter hypoxia metagene | 215 | 1.67 | <0.001 | 0.191 |
Croonquist NRas vs. stromal stimulation up | 33 | 1.64 | 0.006 | 0.211 |
Rickman head and neck cancer | 78 | 1.64 | 0.003 | 0.213 |
Winter hypoxia up | 81 | 1.61 | <0.001 | 0.235 |
Wu cell migration | 166 | 1.59 | <0.001 | 0.244 |